Involvement of dorsolateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats

Amano, 1978, Single neuron analysis of the human midbrain tegmentum. Rostral mesencephalic reticulotomy for pain relief, Appl. Neurophysiol., 41, 66 Bandler, 1994, Columnar organization in the midbrain periaqueductal gray: modules for emotional expression?, Trends Neurosci., 17, 379, 10.1016/0166-2236(94)90047-7 Behbehani, 1995, Functional characteristics of the midbrain periaqueductal gray, Prog. Neurobiol., 46, 575, 10.1016/0301-0082(95)00009-K Bourin, 2004, Cholecystokinin and panic disorder, Acta Neuropsychiatr., 16, 85, 10.1111/j.1601-5215.2004.0076.x Bradwejn, 2001, Cholecystokinin and panic disorder: past and future clinical research strategies, Scand. J. Clin. Lab. Invest., Suppl., 234, 19, 10.1080/713783681 Carrive, 1993, The periaqueductal gray and defensive behavior: functional representation and neuronal organization, Behav. Brain Res., 58, 27, 10.1016/0166-4328(93)90088-8 Deakin, 1991, 5-HT and mechanisms of defense, J. Psychopharmacol., 5, 305, 10.1177/026988119100500414 De Oliveira, 2001, Effects of excitatory amino acids and nitric oxide on flight behavior elicited from the dorsolateral periaqueductal gray, Neurosci. Biobehav. Rev., 25, 679, 10.1016/S0149-7634(01)00050-1 Graeff, 1990, Brain defense systems and anxiety, vol. 3, 307 Graeff, 1991, Neurotransmitters in the dorsal PAG and animal models of panic anxiety, 288 Graeff, 2002, On serotonin and experimental anxiety, Psychopharmacology, 163, 467, 10.1007/s00213-002-1112-4 Graeff, 2004, Serotonin, the periaqueductal gray and panic, Neurosci. Biobehav. Rev., 28, 239, 10.1016/j.neubiorev.2003.12.004 Graeff, 1998, The elevated T-maze as an experimental model of anxiety, Neurosci. Biobehav. Rev., 23, 237, 10.1016/S0149-7634(98)00024-4 Jenck, 1995, Dorsal periaqueductal gray-induced aversion as a simulation of panic anxiety: elements of face and predictive validity, Psychiatry Res., 57, 181, 10.1016/0165-1781(95)02673-K Liu, 1994, Characterization of the effect of cholecystokinin (CCK) on neurons in the periaqueductal gray of the rat: immunocytochemical and in vivo and in vitro electrophysiological studies, Brain Res., 642, 83, 10.1016/0006-8993(94)90908-3 Lovick, 2000, Panic disorder—A malfunction of multiple transmitter control systems within the midbrain periaqueductal gray matter, Neuroscientist, 6, 48, 10.1177/107385840000600113 Mercer, 1996, On the distribution of cholecystokinin B receptors in monkey brain, Brain Res., 738, 313, 10.1016/S0006-8993(96)00477-5 Mongeau, 1997, Effect of central and peripheral administrations of cholecystokinin-tetrapeptide on panic-like reactions induced by stimulation of the dorsal periaqueductal grey area in the rat, Biol. Psychiatry, 42, 335, 10.1016/S0006-3223(96)00407-6 Nashold, 1969, Sensations evoked by stimulation in the midbrain of man, J. Neurosurg., 30, 14, 10.3171/jns.1969.30.1.0014 Netto, 2004, Anxiogenic effect of cholecystokinin in the dorsal periaqueductal gray, Neuropsychopharmacology, 29, 101, 10.1038/sj.npp.1300334 Olds, 1962, Approach–escape interactions in rat brain, Am. J. Physiol., 203, 803, 10.1152/ajplegacy.1962.203.5.803 Paxinos, 1998 Schenberg, 2001, Modeling panic attacks, Neurosci. Biobehav. Rev., 25, 647, 10.1016/S0149-7634(01)00060-4 Schutz, 1985, Anti-aversive role of serotonin in the dorsal periaqueductal grey matter, Psychopharmacology, 85, 340, 10.1007/BF00428199 Singewald, 2000, Neuroanatomical targets of anxiogenic drugs in the hindbrain as revealed by Fos immunocytochemistry, Neurosci., 98, 759, 10.1016/S0306-4522(00)00177-9 Zangrossi, 2001, Serotonergic regulation of inhibitory avoidance and one-way escape in the rat elevated T-maze, Neurosci. Biobehav. Rev., 25, 637, 10.1016/S0149-7634(01)00047-1 Zanoveli, 2004, Systemic and intra-dorsal periaqueductal gray injections of cholecystokinin sulfated octapeptide (CCK-8s) induce a panic-like response in rats submitted to the elevated T-maze, Peptides, 25, 1935, 10.1016/j.peptides.2004.06.016